Table of Content

1.Product Overview
1.1.Market Definition
1.2.Scope of the Market
1.2.1.Markets Covered
1.2.2.Years Considered for Study
1.2.3.Key Market Segmentations
2.Research Methodology
2.1.Objective of the Study
2.2.Baseline Methodology
2.3.Key Industry Partners
2.4.Major Association and Secondary Sources
2.5.Forecasting Methodology
2.6.Data Triangulation Validation
2.7.Assumptions and Limitations
3.Executive Summary
3.1.Overview of the Market
3.2.Overview of Key Market Segmentations
3.3.Overview of Key Market Players
3.4.Overview of Key Regions/Countries
3.5.Overview of Market Drivers, Challenges, Trends
4.Voice of Customer
5.Global Legionella Testing Market Outlook
5.1.Market Size Forecast
5.1.1.By Value
5.2.Market Share Forecast
5.2.1.By Type (Water testing, IVD testing)
5.2.2.By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
5.2.3.By Region
5.2.4.By Company (2023)
5.3.Product Market Map
5.3.1.By Type
5.3.2.By End Use
5.3.3.By Region
6.North America Legionella Testing Market Outlook
6.1.Market Size Forecast
6.1.1.By Value
6.2.Market Share Forecast
6.2.1.By Type (Water testing, IVD testing)
6.2.2.By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
6.2.3.By Country
6.3.North America: Country Analysis
6.3.1.United States Legionella Testing Market Outlook
6.3.1.1.Market Size Forecast
6.3.1.1.1.By Value
6.3.1.2.Market Share Forecast
6.3.1.2.1.By Type
6.3.1.2.2.By End Use
6.3.2.Canada Legionella Testing Market Outlook
6.3.2.1.Market Size Forecast
6.3.2.1.1.By Value
6.3.2.2.Market Share Forecast
6.3.2.2.1.By Type
6.3.2.2.2.By End Use
6.3.3.Mexico Legionella Testing Market Outlook
6.3.3.1.Market Size Forecast
6.3.3.1.1.By Value
6.3.3.2.Market Share Forecast
6.3.3.2.1.By Type
6.3.3.2.2.By End Use
7.Europe Legionella Testing Market Outlook
7.1.Market Size Forecast
7.1.1.By Value
7.2.Market Share Forecast
7.2.1.By Type (Water testing, IVD testing)
7.2.2.By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
7.2.3.By Country
7.3.Europe: Country Analysis
7.3.1.Germany Legionella Testing Market Outlook
7.3.1.1.Market Size Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share Forecast
7.3.1.2.1.By Type
7.3.1.2.2.By End Use
7.3.2.United Kingdom Legionella Testing Market Outlook
7.3.2.1.Market Size Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share Forecast
7.3.2.2.1.By Type
7.3.2.2.2.By End Use
7.3.3.France Legionella Testing Market Outlook
7.3.3.1.Market Size Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share Forecast
7.3.3.2.1.By Type
7.3.3.2.2.By End Use
7.3.4.Italy Legionella Testing Market Outlook
7.3.4.1.Market Size Forecast
7.3.4.1.1.By Value
7.3.4.2.Market Share Forecast
7.3.4.2.1.By Type
7.3.4.2.2.By End Use
7.3.5.Spain Legionella Testing Market Outlook
7.3.5.1.Market Size Forecast
7.3.5.1.1.By Value
7.3.5.2.Market Share Forecast
7.3.5.2.1.By Type
7.3.5.2.2.By End Use
8.Asia-Pacific Legionella Testing Market Outlook
8.1.Market Size Forecast
8.1.1.By Value
8.2.Market Share Forecast
8.2.1.By Type (Water testing, IVD testing)
8.2.2.By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
8.2.3.By Country
8.3.Asia-Pacific: Country Analysis
8.3.1.China Legionella Testing Market Outlook
8.3.1.1.Market Size Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share Forecast
8.3.1.2.1.By Type
8.3.1.2.2.By End Use
8.3.2.Japan Legionella Testing Market Outlook
8.3.2.1.Market Size Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share Forecast
8.3.2.2.1.By Type
8.3.2.2.2.By End Use
8.3.3.India Legionella Testing Market Outlook
8.3.3.1.Market Size Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share Forecast
8.3.3.2.1.By Type
8.3.3.2.2.By End Use
8.3.4.Australia Legionella Testing Market Outlook
8.3.4.1.Market Size Forecast
8.3.4.1.1.By Value
8.3.4.2.Market Share Forecast
8.3.4.2.1.By Type
8.3.4.2.2.By End Use
8.3.5.South Korea Legionella Testing Market Outlook
8.3.5.1.Market Size Forecast
8.3.5.1.1.By Value
8.3.5.2.Market Share Forecast
8.3.5.2.1.By Type
8.3.5.2.2.By End Use
9.South America Legionella Testing Market Outlook
9.1.Market Size Forecast
9.1.1.By Value
9.2.Market Share Forecast
9.2.1.By Type (Water testing, IVD testing)
9.2.2.By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
9.2.3.By Country
9.3.South America: Country Analysis
9.3.1.Brazil Legionella Testing Market Outlook
9.3.1.1.Market Size Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share Forecast
9.3.1.2.1.By Type
9.3.1.2.2.By End Use
9.3.2.Argentina Legionella Testing Market Outlook
9.3.2.1.Market Size Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share Forecast
9.3.2.2.1.By Type
9.3.2.2.2.By End Use
9.3.3.Colombia Legionella Testing Market Outlook
9.3.3.1.Market Size Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share Forecast
9.3.3.2.1.By Type
9.3.3.2.2.By End Use
10.Middle East and Africa Legionella Testing Market Outlook
10.1.Market Size Forecast
10.1.1.By Value
10.2.Market Share Forecast
10.2.1.By Type (Water testing, IVD testing)
10.2.2.By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
10.2.3.By Country
10.3.MEA: Country Analysis
10.3.1.South Africa Legionella Testing Market Outlook
10.3.1.1.Market Size Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share Forecast
10.3.1.2.1.By Type
10.3.1.2.2.By End Use
10.3.2.Saudi Arabia Legionella Testing Market Outlook
10.3.2.1.Market Size Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share Forecast
10.3.2.2.1.By Type
10.3.2.2.2.By End Use
10.3.3.UAE Legionella Testing Market Outlook
10.3.3.1.Market Size Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share Forecast
10.3.3.2.1.By Type
10.3.3.2.2.By End Use
10.3.4.Kuwait Legionella Testing Market Outlook
10.3.4.1.Market Size Forecast
10.3.4.1.1.By Value
10.3.4.2.Market Share Forecast
10.3.4.2.1.By Type
10.3.4.2.2.By End Use
11.Market Dynamics
11.1.Drivers
11.2.Challenges
12.Market Trends Developments
12.1.Recent Development
12.2.Mergers Acquisitions
12.3.Product Launches
13.Porter?s Five Forces Analysis
13.1.Competition in the Industry
13.2.Potential of New Entrants
13.3.Power of Suppliers
13.4.Power of Customers
13.5.Threat of Substitute Products
14.Competitive Landscape
14.1. Abbott Laboratories Inc
14.1.1. Business Overview
14.1.2. Product Offerings
14.1.3. Recent Developments
14.1.4. Financials (As Reported)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Beckman Coulter Inc
14.3. Bio-Rad Laboratories Inc
14.4. BIOM?RIEUX SA
14.5. Eiken Chemical Co Ltd
14.6. Hologic Inc
14.7. Pro-Lab PLC
14.8. QIAGEN NV
14.9. F Hoffmann-La Roche AG
14.10. Takara Bio Inc
14.11. Thermo Fisher Scientific Inc
15.Strategic Recommendations
16.About Us Disclaimer